pharmaceutical-liability
5 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 25-6287 | Marcus Brent Fields v. Pfizer Inc., et al. | Second Circuit | 2025-12-04 | Pending | IFP | corporate-ethics drug-development federal-violations pharmaceutical-liability regulatory-compliance securities-law | a) Pfizer Defendands Knew there Courd ~ TO yotene Lot RA boy , Could ~ Cause more Sever and or Heard damage body orguns damage eS pecially Ceeapmet Am… |
| 24-977 | Merck Sharp & Dohme Corporation v. Doris Albrecht, et al. | Third Circuit | 2025-03-12 | Denied | Amici (4) | administrative-law drug-preemption fda-regulation pharmaceutical-liability state-law-liability warning-label | Whether a pharmaceutical manufacturer can be held liable under state law for failure to warn when the FDA formally denies a proposed warning label cha… |
| 24A720 | Merck Sharp & Dohme Corporation v. Doris Albrecht, et al. | Third Circuit | 2025-01-22 | Presumed Complete | drug-labeling failure-to-warn federal-regulations pharmaceutical-liability preemption product-liability | Whether federal preemption principles under the Wyeth v. Levine framework preclude state law failure-to-warn claims against pharmaceutical manufacture… | |
| 21-1238 | Ina Ann Rodman v. Otsuka America Pharmaceutical, Inc. | Ninth Circuit | 2022-03-11 | Denied | Response Waived | 21-cfr-314-80 design-defect drug-labeling expert-testimony failure-to-warn misbranding pharmaceutical-liability post-marketing-surveillance summary-judgment wyeth-v-levine | Whether Ms. Rodman presented admissible evidence of Otsuka's failure to follow post-marketing surveillance and label revision requirements, and whethe… |
| 18-1502 | Brian Mark Burmaster v. Eli Lilly and Company | Sixth Circuit | 2019-06-03 | Denied | 6th-amendment civil-rights constitutional-rights drug-marketing due-process free-speech government-action government-intervention government-overreach government-regulation medical-ethics pharmaceutical pharmaceutical-liability pharmaceutical-litigation sixth-amendment | If a company's manufactured and marketed product is cited by the US Government as a 'miracle drug' to restore a criminal defendant's Sixth Amendment r… |